Encorafenib

Item number	Size	Delivery time	Price
TGM-T6487-1mg	1 mg	7 - 10 business days*	46.00€
TGM-T6487-5mg	5 mg	7 - 10 business days*	86.00€
TGM-T6487-10mg	10 mg	7 - 10 business days*	122.00€
TGM-T6487-25mg	25 mg	7 - 10 business days*	195.00€
TGM-T6487-50mg	50 mg	7 - 10 business days*	373.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3... more

Close menu

Product information "Encorafenib"

Description: Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity. Target: Raf. Smiles: COC(=O)N[C@@H](C)CNc1nccc(n1)-c1cn(nc1-c1cc(Cl)cc(NS(C)(=O)=O)c1F)C(C)C. References: Darrin D Stuart, et al. Cancer Res, 2012, 72(8 Supplement): 3790

Keywords:	LGX818
Supplier:	TargetMol
Supplier-Nr:	T6487

Properties

Application:	B-Raf V600E mutant inhibitor
MW:	540.01 D
Formula:	C22H27ClFN7O4S

Database Information

CAS :	1269440-17-6\| Matching products
KEGG ID :	K04365 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Encorafenib"

Write a review